Aldosterone/Plasma Renin Direct ratio (B175))
Aldosterone/Plasma Renin Direct ratio (B175))
About This Test
At a Glance
Preparation / Prerequisite
Patient should be ambulatory / upright 2 hours prior to sampling. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be discontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with treating physician.
Test Parameters 1
View All 1 Parameters
- ALDOSTERONE/PLASMA RENIN DIRECT RATIO
Frequently Asked Questions
1. What Is outsourced test ?
2. Any Preparation for the test ?
3. Why this test is important ?
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
